HFA Cardio Talk

With Angela Massouh (Host), American University of Beirut - Lebanon and Loreena Hill (Interviewee), School of Nursing and Midwifery, Queen's University Belfast - United Kingdom In September's HFA cardio podcast Dr. Angela Massouh interviews Dr. Loreena Hill on living with a Left Ventricular Assist Device, lessons learned from around the globe. This podcast will address the lived experiences of patients living with a Left Ventricular Assist Device and their informal caregivers. It will also highlight clinical aspects of self-care and how international multidisciplinary healthcare providers can do better to assist this vulnerable group.

With Emma Louise Robinson (Host), University of Colorado, Aurora, USA. - USA and Luisa Mestroni (Interviewee), University of Colorado, Aurora, USA. In July's HFA Cardio Talk podcast, Dr Emma Robinson interviews Prof Luisa Mestroni, Director of the International Familial Cardiomyopathy Registry and Co-Director of the Molecular Genetics Program of the Cardiovascular Institute in Denver. This podcast discusses current approaches to diagnosis, treatment options and support for patients and families of inherited cardiomyopathy as well as how advances in gene editing have transformed translational research, understanding of disease mechanisms and prospects for clinical care. Relevant website

With Prof. Markus Wallner, Medical University of Graz, Graz - Austria & Rudolf de Boer, University Medical Center Groningen - Netherlands. This podcast will discuss the most recent developments in heart failure with preserved ejection fraction (HFpEF). Prof. de Boer, HFA board member and HFpEF expert, is interviewed by Dr. Wallner, chair of the HoT Committee, and will walk us through the diagnostic and therapeutic challenges of HFpEF and provide tips and tricks for the management of patients with HFpEF.

With Antonio Cannata, King's College London, London - UK, Mateusz Sokolski, Wrocław Medical University, Wrocław - Poland, Otilia Țica, Emergency County Hospital of Oradea, Oradea - Romania, Finn Gustafsson, University of Copenhagen - Danemark, John Cleland, Imperial College of London - UK, Theresa McDonagh, King's College London - UK, Gianluigi Savarese, Karolinska Institute - Sweden, Carolyn Sp Lam, National Heart Centre Singapore - Singapore & Marco Metra, University and Civil Hospital of Brescia, Brescia - Italy This podcast will discuss the insights and highlights shared by key-leaders in heart failure during the annual meeting: Heart Failure Congress, held in Madrid, Spain. Prof. Gustafson offers an overview on advanced heart failure therapies and the role of MCS (mechanical circulatory support). Prof Cleland debates when should we attempt revascularisation in heart failure patients. Prof McDonagh shares the updates and changes in the implementation of the HF guidelines in the last year, since their release. Prof Savarese highlights the best scientific statement of this year, the universal definition of Heart Failure. Prof Lam provides key message and trials in HF and also underlines the sex-differences in these patients. Prof Metra discusses the pillars and future perspectives of HF and the importance of education.

With Petar M. Seferović, Belgrade University, Faculty of Medicine, Belgrade - Serbia & Ivan Milinković, Clinical center of Serbia, Belgrade - Serbia. The podcast discusses how major clinical trials changed the perspective on how randomized clinical trials are designed, conducted and interpreted. It gives the insight into major positive and negative aspects of the clinical trials, which results influenced the contemporary heart failure treatment.

With Gianluigi Savaresse, Karolinska Institute, Stockholm - Sweden & Otilia Țica, University of Medicine of Oradea-Faculty of Medicine and Pharmacy of Oradea, Oradea - Romania.

With Giuseppe Rosano - St George's Hospital Medical School – London - UK & Antonio Cannata - King's College London, London - UK This podcast will discuss the most recent and serendipitous revolution in the field of Heart Failure, the SGLT2-inhibitors, their indications and future perspectives. Prof Rosano, interviewed by Dr Cannata, will drive through the most recent evidence supporting the use of SGLT2-i in patients with heart failure. Let's see whether an apple a day truly keeps the doctor away.

With Ewa A. Jankowska & Mateusz Sokolski, Institute of Heart Diseases, Wroclaw Medical University, University Hospital, Wroclaw - Poland Link to paper